558
Views
16
CrossRef citations to date
0
Altmetric
Articles

Hepatoprotective Effect of Probiotic Lactobacillus rhamnosus GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in Zebrafish

, , , , , , , , , , , & show all
Pages 163-170 | Received 09 Apr 2019, Accepted 03 Jun 2019, Published online: 26 Jun 2019

References

  • World Health Organization. Global status report on alcohol and health. WHO Library Cataloguing-in-Publication Data, 2014. Available from: http://www.worldgastroenterology.org/UserFiles/file/guidelines/probiotics-and-prebiotics-english-2017.pdf [Accessed 2019 June 13].
  • O’Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatol. 2010;51(1):307–328. Available from: doi:10.1002/hep.23258.
  • Kirpich IA, Feng W, Wang Y, Liu Y, Barker DF, Barve SS, et al. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcohol Clin Exp Res. 2012;36(5):835–46. doi:10.1111/j.1530-0277.2011.01673.x.
  • Xue L, He J, Gao N, Lu X, Li M, Wu X, et al. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Sci Rep. 2017;7(March):1–13.
  • Ceccarelli S, Nobili V, Alisi A. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. WJG. 2014;20(44):16443–16451. doi:10.3748/wjg.v20.i44.16443.
  • Chen P, Stärkel P, Turner JR, Ho SB, Schnabl B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology. 2015;61(3):1–8.
  • Günzel D, Yu A. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93(2):525–569. doi:10.1152/physrev.00019.2012.
  • Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, et al. Probiotics and Prebiotics. 2011. Available from: http://www.worldgastroenterology.org/probiotics-prebiotics.html [Accessed 2019 January 8].
  • Brandl K, Schnabl B. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?. Expert Rev Gastroenterol Hepatol. 2015;9(8):1069–1076. doi:10.1586/17474124.2015.1057122.
  • Szabo G, Csak T. Review inflammasomes in liver diseases. 2012;57:642–54.
  • Davis BK, Wen H, Ting J. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29(1):707–735. doi:10.1146/annurev-immunol-031210-101405.
  • Wu X, Dong L, Lin X, Li J. Relevance of the NLRP3 inflammasome in the pathogenesis of chronic liver disease. Front Immunol. 2017;8(DEC):1–10.
  • Cui K, Yan G, Xu C, Chen Y, Wang J, Zhou R, Bai L, Lian Z, Wei H, Sun R, et al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice. J Hepatol. 2015;62(6):1311–1318. doi:10.1016/j.jhep.2014.12.027.
  • Ma Y-Y, Li L, Yu C-H, Shen Z, Chen L-H, Li Y-M. Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis. WJG. 2013;19(40):6911. Available from: http://www.wjgnet.com/1007-9327/full/v19/i40/6911.htm
  • Chu H, Williams B, Schnabl B. Gut microbiota, fatty liver disease, and hepatocellular carcinoma. Liver Res. 2018;2(1):1–9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2542568418000041
  • Shi X, Wei X, Yin X, Wang Y, Zhang M, Zhao C, Zhao H, McClain CJ, Feng W, Zhang X, et al. Hepatic and fecal metabolomic analysis of the effects of Lactobacillus rhamnosus GG on alcoholic fatty liver disease in mice. J Proteome Res. 2015;14(2):1174–1182. doi:10.1021/pr501121c.
  • Wree A, Marra F. The inflammasome in liver disease financial support conflict of interest acknowledgements. J Hepatol. 2018;63(5):5–7.
  • Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 1999 December. 4th ed. Eugene: University of Oregon Press; 1999.
  • Meurer F, Hayashi C, Boscolo WR. Digestibilidade aparente de alguns alimentos protéicos pela tilápia do Nilo (Oreochromis niloticus. Rev Bras Zootec. 2003;32(6):1–11.
  • Schneider ACR, Machado ABMP, de Assis AM, Hermes DM, Schaefer PG, Guizzo R, Fracasso LB, de-Paris F, Meurer F, Barth AL, et al. Effects of Lactobacillus rhamnosus GG on hepatic and serum lipid profiles in zebrafish exposed to ethanol. Zebrafish. 2014;11(4):371–8. Available from: doi:10.1089/zeb.2013.0968.
  • Wilson JM, Bunte RM, Carty AJ. Evaluation of rapid cooling and tricaine methanesulfonate (MS222) as methods of euthanasia in zebrafish (Danio rerio). J Am Assoc Lab Anim Sci [Internet]. 2009;48(6):785–789. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19930828%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2786934
  • Schneider ACR, Gregório C, Uribe-Cruz C, Guizzo R, Malysz T, Faccioni-Heuser MC, Longo L, da Silveira TR. Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver. WJH.. 2017;9(8):418–426. doi:10.4254/wjh.v9.i8.418.
  • Mehlem A, Hagberg CE, Muhl L, Eriksson U, Falkevall A. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc. 2013;8(6):1149–1154. doi:10.1038/nprot.2013.055.
  • Ouwehand A, Saxelin M, Salminen S. Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin Infect Dis. 2004;39(12):1858–1860. 15():doi:10.1086/425741.
  • Zhang M, Wang C, Wang C, Zhao H, Zhao C, Chen Y, Wang Y, McClain C, Feng W. Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease. J Nutr Biochem. 2015;26(4):337–344. doi:10.1016/j.jnutbio.2014.10.016.
  • Kim B, K-Y, Park Y, Ji S, Park W, Holzapfel CH. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice. Arch Biochem Biophys. 2016;473(2):530–536. Available from: doi:10.1016/j.bbrc.2016.03.107.
  • Sekirov I, Russell L, Antunes CM, Finlay BB. Gut Microbiota in Health and Disease. Physiol Rev. 2010;90(3):859–904. (doi:10.1152/physrev.00045.2009.
  • Cinaroglu A, Gao C, Imrie D, Sadler KC. Atf6 plays protective and pathologic roles in fatty liver disease due to endoplasmic reticulum stress. Hepatology. 2011;54(2):1–42.
  • Silveira T. D, Schneider AC, Hammes TO. Zebrafish: modelo consagrado para estudos de doenças humanas. Cienc Cult. 2012;64(2):4–5. Available from: http://cienciaecultura.bvs.br/scielo.php?script=sci_arttext&pid=S0009-67252012000200002&lng=en&nrm=iso&tlng=pt
  • Shimada Y, Kuninaga S, Ariyoshi M, Zhang B, Shiina Y, Takahashi Y, et al. E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish. Nutr Metab (Lond) [Internet]. 2015;12(1):17. Available from: http://www.nutritionandmetabolism.com/content/12/1/17
  • Nanji AA, Khettry U, Sadrzadeh S. Lactobacillus Feeding Reduces Endotoxemia and Severity of Experimental Alcoholic Liver (Disease). Exp Biol Med. 1994;205(3):243–247. Available from: doi:10.3181/00379727-205-43703.
  • Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009;43(2):163–172. doi:10.1016/j.alcohol.2008.12.009.
  • McClain CJ, Cohen DA, Dinarello CA, Cannon JG, Shedlofsky SI, Kaplan AM. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci. 1986;39(16):1479–1485.
  • Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol. 2015;12(7):387–400. Available from: http://www.nature.com/doifinder/10.1038/nrgastro.2015.94 doi:10.1038/nrgastro.2015.94.
  • Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min S-Y, Kurt-Jones EA, Szabo G, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest. 2012;122(10):3476–3489. doi:10.1172/JCI60777.
  • Wang Y, Liu Y, Kirpich I, Ma Z, Wang C, Zhang M, Suttles J, McClain C, Feng W. Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury. J Nutr Biochem. 2013;24(9):1609–1615. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23618528%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3804118 doi:10.1016/j.jnutbio.2013.02.001.
  • Ritze Y, Bárdos G, Claus A, Ehrmann V, Bergheim I, Schwiertz A, et al. Lactobacillus rhamnosus GG Protects against non-alcoholic fatty liver disease in mice. PLoS One. 2014;9(1):1–9.
  • Volynets V, Louis S, Pretz D, Lang L, Ostaff MJ, Wehkamp J, Bischoff SC. Intestinal Barrier Function and the Gut Microbiome Are Differentially Affected in Mice Fed a Western-Style Diet or Drinking Water Supplemented with Fructose. J Nutr. 2017;147(5):770–780. Available from: doi:10.3945/jn.116.242859.
  • Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, Liu Y, et al. Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG Treatment. PLoS One. 2013;8(1):4–13.
  • Singh V, Sharma J, Babu S, Singla A. Role of probiotics in health and disease: a review. JPMA J. 2013;253–257. Available from: http://europepmc.org/abstract/med/23894906

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.